1. Venulet J, Bankowski Z. Harmonising adverse drug reaction terminology: the role of the Council for International Organizations of Medical Sciences. Drug Saf. 1998;19:165-72.

https://doi.org/10.2165/00002018-199819030-00001

PMid:9747664 

2. Edwards IR, Aronson JK. Adverse drug reactions: definitions, diagnosis, and management. Lancet. 2000;356:1255-9.

https://doi.org/10.1016/S0140-6736(00)02799-9

PMid:11072960

3. Goedecke T, Ord K, Newbould V, Brosch S, Arlett P. Medication Errors: New EU Good Practice Guide on Risk Minimisation and Error Prevention. Drug Saf. 2016;39:491-500.

https://doi.org/10.1007/s40264-016-0410-4

PMid:26940903 

4. Pirmohamed M, James S, Meakin S, Green C, Scott AK, Walley TJ, et al. Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients. BMJ. 2004;329:15-9.

https://doi.org/10.1136/bmj.329.7456.15

PMid:15231615 PMCid:PMC443443

5. Donaldson LJ, Kelley ET, Dhingra-Kumar N, Kieny MP, Sheikh A. Medication Without Harm: WHO's Third Global Patient Safety Challenge. Lancet. 2017;389:1680-1.

https://doi.org/10.1016/S0140-6736(17)31047-4

PMid:28463129

6. Rosebush MS, Briody AN, Cordell KG. Black and Brown: Non-neoplastic Pigmentation of the Oral Mucosa. Head Neck Pathol. 2019;13:47-55.

https://doi.org/10.1007/s12105-018-0980-9

PMid:30671761 PMCid:PMC6405786

7. Tavares TS, Meirelles DP, de Aguiar MCF, Caldeira PC. Pigmented lesions of the oral mucosa: A cross-sectional study of 458 histopathological specimens. Oral Dis. 2018;24:1484-91.

https://doi.org/10.1111/odi.12924

PMid:29945290 

8. Abdollahi M, Radfar M. A review of drug-induced oral reactions.J Contemp Dent Pract. 2003;4:10-31.

https://doi.org/10.5005/jcdp-4-1-10

PMid:12595930 

9. Eisen D. Disorders of pigmentation in the oral cavity. Clin Dermatol. 2000;18:579-87.

https://doi.org/10.1016/S0738-081X(00)00148-6

PMid:11134853

10. Binmadi NO, Bawazir M, Alhindi N, Mawardi H, Mansour G, Alhamed S, et al. Medication-Induced Oral Hyperpigmentation: A Systematic Review. Patient Prefer Adherence. 2020;14:1961-68.

https://doi.org/10.2147/PPA.S275783

PMid:33116439 PMCid:PMC7573322

11. Rodríguez-Terol A, Caraballo MO, Palma D, Santos-Ramos B, Molina T, Desongles T, et al. Quality of interaction database management systems. Farm Hosp. 2009;33:134-46.

https://doi.org/10.1016/S1130-6343(09)71155-9

PMid:19712597

12. Abarca J, Malone DC, Armstrong EP, Grizzle AJ, Hansten PD, van Bergen RC, et al. Concordance of severity ratings provided in four drug interaction compendia. J Am Pharm Assoc. 2004;44:136-41.

https://doi.org/10.1331/154434504773062582

PMid:15098847 

13. Kontsioti E, Maskell S, Bensalem A, Dutta B, Pirmohamed M. Similarity and Consistency Assessment of Three Major Online Drug-Drug Interaction Resources. Br J Clin Pharmacol. 2022.

https://doi.org/10.1111/bcp.15341

PMid:35362214 

14. Vitry AI. Comparative assessment of four drug interaction compendia. Br J Clin Pharmacol. 2007;63:709-14.

https://doi.org/10.1111/j.1365-2125.2006.02809.x

PMid:17166171 PMCid:PMC2000587

15. Tosios KI, Kalogirou EM, Sklavounou A. Drug-associated hyperpigmentation of the oral mucosa: report of four cases. Oral Surg Oral Med Oral Pathol Oral Radiol. 2018;125:e54-66.

https://doi.org/10.1016/j.oooo.2017.10.006

PMid:29287748 

16. Sreeja C, Ramakrishnan K, Vijayalakshmi D, Devi M, Aesha I, Vijayabanu B. Oral pigmentation: a review. J Pharm Bioallied Sci. 2015;7:403-8.

https://doi.org/10.4103/0975-7406.163471

PMid:26538887 PMCid:PMC4606629

17. Gaeta GM, Satriano RA, Baroni A. Oral pigmented lesions. Clin Dermatol. 2002;20:286-8.

https://doi.org/10.1016/S0738-081X(02)00225-0

PMid:12074869

18. Siller GM, Tod MA, Savage NW. Minocycline-induced oral pigmentation. J Am Acad Dermatol. 1994;30:350-4.

https://doi.org/10.1016/S0190-9622(94)70038-9

PMid:8294596

19. Tosios KI, Kalogirou EM, Sklavounou A. Drug-associated hyperpig- mentation of the oral mucosa: report of four cases. Oral Surg Oral Med Oral Pathol Oral Radiol. 2018;125:e54-66.

https://doi.org/10.1016/j.oooo.2017.10.006

PMid:29287748 

20. Bahloul E, Jallouli M, Garbaa S, Marzouk S, Masmoudi A, Turki H, et al. Hydroxychloroquine-induced hyperpigmentation in systemic diseases: prevalence, clinical features and risk factors: a cross-sectional study of 41 cases. Lupus. 2017;26:1304-8.

https://doi.org/10.1177/0961203317700486

PMid:28355984 

21. Khoo TL, Catalano A, Supple S, Chong L, Yeoh SC, Yeung S, et al. Hyperpigmentation of the hard palate associated with imatinib therapy for chronic myeloid leukemia with a genetic variation in the proto-oncogene c-KIT. Leuk Lymphoma. 2013;54:186-8.

https://doi.org/10.3109/10428194.2012.702904

PMid:22712835 

22. Mcpherson T, Sherman V, Turner R. Imatinib-associated hyperpigmentation, a side effect that should be recognized. J Eur Acad Dermatol Venereol. 2009;23:82-3.

https://doi.org/10.1111/j.1468-3083.2008.02706.x

PMid:18384557 

23. Dai J, Belum VR, Wu S, Sibaud V, Lacouture ME. Pigmentary changes in patients treated with targeted anticancer agents:a systematic review and meta-analysis. J Am Acad Dermatol. 2017;77:902-10.e2.

https://doi.org/10.1016/j.jaad.2017.06.044

PMid:28918974 PMCid:PMC5657394

24. Steele JC, Triantafyllou A, Rajlawat BPFE, Field EA. Oral mucosal hyperpigmentation and horizontal melanonychia caused by imatinib.Clin Exp Dermatol. 2012;37:432-3.

https://doi.org/10.1111/j.1365-2230.2011.04196.x

PMid:22420895 

25. Oliveira SR, de Azevedo Branco LG, Rocha AL, Travassos DV, Magalhães GHR, Fonseca FP, et al. Association of oral mucosa hyperpigmentation with imatinib mesylate use: a cross-sectional study and a systematic literature review. Clin Oral Investig. 2019;23:4371-82.

https://doi.org/10.1007/s00784-019-02886-0

PMid:30968242 

26. Veillet-Lemay G, Haber RM. Hydroxyurea-Induced Oral Hyperpigmentation: A Case Report and Review of the Literature. J Cutan Med Surg. 2019;23:111-3.

https://doi.org/10.1177/1203475418803074

PMid:30232899 

27. de Filho MRM, da Silva CAD, da Dourado MR, de Pires MBO, Pêgo SPB, de Freitas EM. Palate hyperpigmentation caused by prolonged use of the anti-malarial chloroquine. Head Neck Pathol. 2012;6:48-50.

https://doi.org/10.1007/s12105-011-0288-5

PMid:21877232 PMCid:PMC3311937

28. Birek C, Main JH. Two cases of oral pigmentation associated with quinidine therapy. Oral Surg Oral Med Oral Pathol. 1988;66:59-61.

https://doi.org/10.1016/0030-4220(88)90067-9

PMid:3165515

29. Watson IB, MacDonald DG. Amodioquine induced oral pigmentation - a light and electron microscopic study. J Oral Pathol Med. 1974;3:16-21.

https://doi.org/10.1111/j.1600-0714.1974.tb01694.x

PMid:4208872 

30. Eljaaly K, Alireza KH, Alshehri S, Al-Tawfiq JA. Hydroxychloroquine safety: a meta-analysis of randomized controlled trials. Travel Med Infect Dis. 2020;36:101812.

https://doi.org/10.1016/j.tmaid.2020.101812

PMid:32645478 PMCid:PMC7342171

31. Ficarra G, Shillitoe EJ, Adler-Storthz K, Gaglioti D, Di Pietro M, Riccardi R, et al. Oral melanotic macules in patients infected with human immunodeficiency virus. Oral Surg Oral Med Oral Pathol. 1990;70:748-55.

https://doi.org/10.1016/0030-4220(90)90014-J

PMid:2175872

32. Ozturk R, Engin A, Ozaras R, Mert A, Tabak F, Aktuglu Y. Hyperpigmentation due to pyrimethamine use. The Journal of Dermatology. 2002;29:443.

https://doi.org/10.1111/j.1346-8138.2002.tb00303.x

PMid:12184645